Telo Genomics Corp (TELO)

Currency in CAD
0.08
0.00(0.00%)
Closed·
Trading near 52-week Low
Fair Value
Day's Range
0.080.09
52 wk Range
0.080.20
Key Statistics
Bid/Ask
0.08 / 0.08
Prev. Close
0.08
Open
0.09
Day's Range
0.08-0.09
52 wk Range
0.08-0.2
Volume
2K
Average Volume (3m)
8.38K
1-Year Change
-55.56%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TELO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Telo Genomics Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Telo Genomics Corp Company Profile

Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions primarily in Canada. Its TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive of genomic instability to identify specific disease mechanisms, predict disease risks, and determine effective treatments. Its lead product is TeloView-SMM (Smoldering Multiple Myeloma) for SMM patients with high risk of transition to multiple myeloma (MM). The company also develops TeloView NDMM that predicts newly diagnosed MM patients who may relapse on 1st line therapy; TeloMRD-D Enumaeration that identifies and enumerates MRD cells in post-transplant patients; and TeloViewNG-MRD (Minimal Residual Disease) Profiling for genomic instability profiling of MRD detected cells in post-transplant patients. It has a collaboration agreement with the Mayo Clinic. Telo Genomics Corp. is headquartered in Toronto, Canada.

Compare TELO to Peers and Sector

Metrics to compare
TELO
Peers
Sector
Relationship
P/E Ratio
0.0x−3.8x−0.5x
PEG Ratio
0.000.040.00
Price/Book
0.0x1.4x2.6x
Price / LTM Sales
0.0x2.4x3.3x
Upside (Analyst Target)
0.0%251.9%43.5%
Fair Value Upside
Unlock−1.2%6.3%Unlock

Earnings

Latest Release
Feb 28, 2023
EPS / Forecast
-0.01 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

TELO Income Statement

FAQ

What Stock Exchange Does Telo Genomics Corp Trade On?

Telo Genomics Corp is listed and trades on the CBOE Canada Exchange stock exchange.

What Is the Stock Symbol for Telo Genomics Corp?

The stock symbol for Telo Genomics Corp is "TELO."

What Is the Telo Genomics Corp Market Cap?

As of today, Telo Genomics Corp market cap is 7.53M.

What Is Telo Genomics Corp's Earnings Per Share (TTM)?

The Telo Genomics Corp EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is TELO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Telo Genomics Corp Stock Split?

Telo Genomics Corp has split 2 times.

What is the current trading status of Telo Genomics Corp (TELO)?

As of 05 Aug 2025, Telo Genomics Corp (TELO) is trading at a price of 0.08, with a previous close of 0.08. The stock has fluctuated within a day range of 0.08 to 0.09, while its 52-week range spans from 0.08 to 0.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.